NRX Pharmaceuticals
NRXP
NRXP
32 hedge funds and large institutions have $13.2M invested in NRX Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.95% more ownership
Funds ownership: 17.68% → 18.63% (+0.95%)
7% less capital invested
Capital invested by funds: $14.2M → $13.2M (-$1.02M)
Holders
32
Holding in Top 10
1
Calls
$470K
Puts
$285K
Top Buyers
| 1 | +$6.06M | |
| 2 | +$187K | |
| 3 | +$184K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$159K |
| 5 |
HT
Headlands Technologies
Chicago,
Illinois
|
+$79.5K |
Top Sellers
| 1 | -$8.25M | |
| 2 | -$47.3K | |
| 3 | -$43.3K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$8.78K |
| 5 |
Morgan Stanley
New York
|
-$2 |
